About this episode
In What's Trending in Aesthetics? we discuss the topics doing the rounds on social media, in injector forums and in the news: the controversies, big stories and themes getting our industry talking.
In Chapter 14, recorded in our new studio, Dr Jake and David explore the global rise of GLP-1 medications and their impact on aesthetic practices.
They discuss the huge UK price hike for Mounjaro and what tariffs could mean for the price of aesthetic products, gross margins and pharmaceutical price discrepancies.
They also ask whether Kris Jenner's facelift means not looking your age is the new normal, and explain Botox's new on-label indication for platysmal bands and why injectors can't afford to ignore the neck.
What you'll learn
- How GLP-1 medications are changing aesthetic practice
- What the Mounjaro price hike signals for product pricing
- Understanding gross margins in your clinic
- What 'natural' means after a celebrity facelift
- The new on-label indication for platysmal bands
- Improving your consultation process
Topics
- What's trending
- GLP-1
- Pricing
- Facelift
- Platysma
- Botulinum toxin
- Industry news
Full transcript
The full transcript for this episode is coming soon.